COYA logo

Coya Therapeutics, Inc. Common Stock


COYA: Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.


Show COYA Financials

Consumer Interest
SEC Filings

Recent trades of COYA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by COYA's directors and management

Government lobbying spending instances

  • $10,000 Jul 19, 2022 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $10,000 Apr 19, 2022 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of COYA in WallStreetBets Daily Discussion


Recent insights relating to COYA

CNBC Recommendations

Recent picks made for COYA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in COYA

Corporate Flights

Flights by private jets registered to COYA